cannabis
GW Pharma’s cannabidiol gains EC approval
April 21, 2021Research and Development EC, EU, cannabis
GW Pharmaceuticals has received European Commission (EC) approval for the type II variation application for Epidyolex (cannabidiol), as an adjunctive …
NHS guidelines on prescription cannabis to be challenged in court
August 18, 2020Manufacturing and Production, Research and Development CBD, cannabis, epilepsy
The cannabis guidelines followed by the NHS are set to be challenged in court by the parents of a three-year-old …
UK Home office reclassifies Epidyolex as a Schedule 5 drug
June 24, 2020Research and Development CBD, cannabiodiol, cannabis
The Home Office has announced that the drug Epidyolex (cannabidiol) has been reclassified as a Schedule 5 drug, a move …
NHS to fast track cannabis-based treatment for epilepsy
December 23, 2019Sales and Marketing CBD, CBD Oil, cannabis, drug treatment, epilepsy, thc
The NHS has fast-tracked the drug Epidyolex, a cannabidiol (CBD), to be available for epilepsy treatment through the NHS in …
British Pharmacists call for regulation on non-medicinal CBD products
December 17, 2019Manufacturing and Production CBD, CBD Oil, CBD Products, cannabis
Pharmacists are calling for more checks on products containing Cannabis derivative cannabidiol (CBD) that are sold in shops across the …
A new weapon against Parkinson’s-related psychosis
December 16, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Parkinson's disease, cannabidiol, cannabis, feature, pharma
Dr Arthur Roach, Director of Research at the charity Parkinson’s UK, discusses new trials on cannabidiol in the treatment of …
NICE refuses GW Pharma’s cannabis-based Epidyolex for treatment-resistant epilepsy
August 27, 2019Manufacturing and Production, Sales and Marketing Epidiolex, Epidyolex, GW Pharma, NICE, cannabidiol, cannabis, pharma
UK-based GW Pharma has suffered a setback in its home country after drug watchdog NICE chose not to recommend NHS …
Hundreds of patients turn to private cannabis clinics in UK
August 16, 2019Medical Communications Marijuana, NHS, UK, cannabis, medicinal cannabis, pharma
Hundreds of people have turned to private clinics, in an effort to gain access to medicinal cannabis in the UK, …
Medicinal cannabis company Spectrum makes first shipment into UK
August 7, 2019Research and Development Spectrum, UK, cannabis, medicinalcannabis, pharma
Medicinal cannabis company Spectrum Europe has made its first shipment of cannabis into the UK, making it one of the …
GW Pharma’s cannabis-based Epidyolex edges closer to EU approval with positive CHMP opinion in epilepsy
July 26, 2019Medical Communications, Sales and Marketing EMA, Epidiolex, Europe, GW Pharma, cannabis, epilepsy
UK-based biotech GW Pharmaceuticals has announced that its cannabidiol oral solution Epidyolex has secured recommendation from the European Medicines Agency’s …
Top Ten most popular articles on Pharmafile.com this week!
July 5, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Brenntag, Elizabeth Warren, HIV, Novartis, PrEP, cannabis, crispr, pharma
The top story of this week covered Novartis’ announcement that they did not send chemicals that could be used to …
GW Pharma’s Epidiolex scores in rare childhood onset epilepsy Phase 3 trial
May 7, 2019Manufacturing and Production, Sales and Marketing CBD, Epidiolex, GW Pharma, cannabidiol, cannabis, epilepsy, tsc
GW Pharma’s Epidiolex has shown positive Phase 3 trial results for the fifth time in a row, after meeting primary …
Medical cannabis: A green light for patients in need?
April 15, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Insider Interview, Medical marijuana, cannabis, feature, pharma
Spinnaker Opportunities announced in February it had reached a preliminary agreement to acquire cannabis oil-focused research firm Kanabo Research and …
Africa’s legal cannabis market could generate $7.1 billion each year by 2023
March 25, 2019Sales and Marketing Africa, UN, cannabis, medicnial cannabis, prohibition partners
Africa’s legal cannabis market could generate more than $7.1 billion each year by 2023, according to a report from market …
Scientists genetically modify yeast to produce CBD and THC
February 28, 2019Research and Development Medical marijuana, berkely, cannabis, science, yeast
Researchers at the University of California, Berkeley have genetically modified brewer’s yeast so that it produces two common cannabinoids: tetrahydrocannabinol …
